Search | Webyourself Social Media Platform

Leena Leena added article Health
2024-10-18 11:58:54 -

Dyslexia Treatment Market Expected To Grow At A Rapid Pace Due To Advances
Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Key TakeawaysKey players operating in the dyslexia treatment market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli...

0 Comments 0 Shares 88 Views 0 Reviews

Please log in to like, share and comment!
Leena Leena added article Health
2024-05-24 12:02:58 -

Dyslexia Treatment Market is driven by increasing awareness and early diagnosis rates
The dyslexia treatment market comprises of drugs such as amphetamines or stimulants, anti-depressants, and multimodal therapies which help in providing cognitive behavioral therapy to dyslexic individuals. Dyslexia refers to a specific type of learning disorder where individuals face difficulties with reading, writing, and spelling despite normal intelligence. Dyslexia is a persistent...

0 Comments 0 Shares 654 Views 0 Reviews

Please log in to like, share and comment!
Leena Leena added article Health
2024-06-28 12:45:06 -

Dyslexia Treatment Market is driven by Increasing Prevalence of Dyslexia
The Global dyslexia treatment market is estimated to be valued at US$ 7.59 Bn in 2024 and is expected to exhibit a CAGR of 6.4% over the forecast period from 2024 to 2031. The increasing prevalence of dyslexia worldwide along with growing awareness levels regarding learning disabilities are major factors driving the growth of the dyslexia treatment market. Furthermore, the development of novel...

0 Comments 0 Shares 563 Views 0 Reviews

Please log in to like, share and comment!
Leena Leena added article Health
2024-07-30 11:14:18 -

Dyslexia Treatment Market is Estimated to Witness High Growth Owing to Advancements
Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Key TakeawaysKey players operating in the dyslexia treatment market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli...

0 Comments 0 Shares 492 Views 0 Reviews

Please log in to like, share and comment!